Clinical RoundupFree Phase III trial evaluating Libtayo in NSCLC halted because of significant OS improvement May 01, 2020Vol.46 No.18
Clinical RoundupFree Lynparza demonstrates OS benefit in phase III prostate cancer trial May 01, 2020Vol.46 No.18
Clinical RoundupFree GARNET study demonstrates potential of dostarlimab to treat recurrent or advanced endometrial cancer May 01, 2020Vol.46 No.18
Clinical RoundupFree MD Anderson, Ipsen advance therapy with potential benefit for patients with lung, ovarian cancer May 01, 2020Vol.46 No.18
Clinical RoundupFree Study: Disruptions in health insurance coverage are common, and affect cancer care and survival May 01, 2020Vol.46 No.18
Clinical RoundupFree Mouse model study shows promise in treatment of medulloblastoma and ependymoma May 01, 2020Vol.46 No.18
Clinical RoundupFree Phase III CheckMate-743 study of Opdivo and Yervoy meets primary OS endpoint in mesothelioma April 24, 2020Vol.46 No.17
Clinical RoundupFree Phase III CheckMate -9ER meets primary PFS endpoint in RCC April 24, 2020Vol.46 No.17
Clinical RoundupFree New targeted agent produces responses in trial with patients with uterine serous carcinoma April 24, 2020Vol.46 No.17
